Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of loxoprofen sodium gel patch for chronic inflammatory pain
ChiCTR2100052780Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of loxoprofen in chronic inflammatory pain, osteoarthritis (OA) and adhesive capsulitis (AC), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Treatment effectiveness rate, Visual analogue scale scoring and 3 more. Started Dec 2021; status: recruiting.
02
Drugs
loxoprofen
03
Conditions
chronic inflammatory painosteoarthritis (OA)adhesive capsulitis (AC)
Beyond the preview
Go deeper on ChiCTR2100052780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052780.